AlphaQuest’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,521
Closed -$2.23M 1134
2025
Q4
$2.23M Buy
27,521
+16,744
+155% +$1.44M 0.12% 168
2025
Q3
$943K Buy
10,777
+3,214
+42% +$287K 0.06% 452
2025
Q2
$628K Sell
7,563
-940
-11% -$78.6K 0.06% 499
2025
Q1
$713K Buy
8,503
+8,417
+9,787% +$783K 0.08% 399
2024
Q4
$7.92K Sell
86
-2,769
-97% -$266K ﹤0.01% 1509
2024
Q3
$265K Buy
+2,855
New +$247K 0.02% 950
2024
Q2
Sell
-7
Closed -$465 1750
2024
Q1
$465 Sell
7
-64
-90% -$3.95K ﹤0.01% 1528
2023
Q4
$4.03K Buy
+71
New +$3.72K ﹤0.01% 1011

Other funds holding LMAT

AlphaQuest's LMAT Position: Q1 2026 in Review

AlphaQuest sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 27,521 shares — an estimated $2.23M sold.

AlphaQuest first reported a position in LMAT in Q4 2023 and held it in 8 quarters. The position peaked at $2.23M in Q4 2025. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • AlphaQuest reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 27,521 LeMaitre Vascular shares in Q1 2026, an estimated $2.23M.
  • AlphaQuest first reported a position in LeMaitre Vascular in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's LeMaitre Vascular position peaked at $2.23M in Q4 2025.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.